Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecamylamine Add-On to Citalopram in MDD
NCT00593879Phase 2Completed
- Sponsor
- Targacept
- Start
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mecamylamine in major depressive disorder (MDD), sponsored by Targacept. Started Feb 2005; status: completed.
02
Drugs
mecamylamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00593879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593879.